The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Showing 8 / 1361 articles
Psyllium husk is gaining viral attention for its digestive and metabolic benefits. But is it truly a weight loss solution comparable to GLP-1 medications? We break down the evidence.
Comedian Amy Schumer recently shared a selfie highlighting her weight loss and C-section scar, opening up about her diagnosis of Cushing's syndrome and her path to health.
New data presented at ENDO 2026 reveals a paradox: patients on GLP-1 medications like Ozempic and Wegovy reduced their physical activity despite losing weight.
A new clinical trial suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may help slow biological processes associated with aging in adults with HIV.
While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.
A major study from Penn Medicine reveals a potential link between GLP-1 medications like Ozempic and a significant reduction in breast cancer risk, offering new hope for preventive care.
The new oral Wegovy formulation has arrived, but hair shedding concerns remain. Discover the science behind the risk and three actionable lifestyle changes to protect your hair health while on semaglutide.
Explore the groundbreaking research linking GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, to a reduced risk of substance use disorders and fewer addiction-related emergencies.
